secwatch.observer — SEC 8-K summary
======================================

Issuer:     NovoCure Ltd (NVCR)
CIK:        0001645113
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001645113-25-000045
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novocure appoints President Frank Leonard as CEO; Ashley Cordova resigns
------------------------------------------------------------------------

- Ashley Cordova resigned as CEO and director effective Nov 30, 2025; no disagreement related to operations.
- Frank Leonard, previously President, becomes CEO effective Dec 1, 2025; he joined Novocure in 2010.
- Cordova enters garden leave through May 31, 2026, with salary, benefits, bonus, and CHF 375,000 cash payment.
- Leonard led global business operations since Jan 2024 and prior innovation/product development.
- Executive Chairman William Doyle cites Leonard as ideal for upcoming transformative milestones.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645113/000164511325000045/0001645113-25-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645113/000164511325000045/nvcr-20251124.htm
  HTML page:      https://secwatch.observer/filing/0001645113-25-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer